Skip to main content

Table 1 Basal endocrine evaluation

From: Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report

Hormone Level measured Normal levels
GH 0.360 ng/mL 0.010–3.607 ng/mL
PRL 6.83 ng/mL <12.3 ng/mL
TSH 1.288 μIU/mL 0.350–4.940 μIU/mL
FT3 1.78 pg/mL 1.71–3.71 pg/mL
FT4 <0.40 ng/dL 0.70–1.48 ng/dL
ACTH 1.4 pg/mL 7.2–63.3 pg/mL
Cortisol 3.1 μg/dL 4.0–19.3 μg/dL
Aldosterone 10 pg/mL 36–240 pg/mL
Plasma renin activity 0.5 ng/mL 0.2–3.9 ng/mL
ADH 0.27 pg/mL 0.3–4.2 pg/mL
LH <0.10 mIU/mL 7.5–56.2 mIU/mL
FSH 0.27 mIU/mL 9.2–124.7 mIU/mL
  1. Bold text indicates abnormal data
  2. GH: growth hormone, PRL: prolactin, TSH: thyroid-stimulating hormone, FT3: free triiodothyronine, FT4: free thyroxine, ACTH: adrenocorticotropic hormone, ADH: antidiuretic hormone, LH: luteinizing hormone, FSH: follicle-stimulating hormone